11 January 2022 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
In this article, the authors indicate the main methods of surgical treatment of patients with varicose veins of the lower extremities. The main issues related to endovenous methods of varicose vein obliteration are analyzed and described. Literary sources were searched for by keywords in the international abstract database PubMed. gov, as well as the Russian RSCI system over the past 20 years. Over 50 scientific publications have been studied. With the use of modern methods of treating patients with varicose veins of the lower extremities, the number of outpatient procedures is increasing, while improving the quality of life.
24 March 2023 in Journal of Venous Disorders
Objective. To compare the results of short-term and extended compression therapy after sclerotherapy in patients with reticular varicose veins and telangiectasias. Material and methods. A comparative non-randomized study included 72 patients with reticular varicose veins and/or telangiectasias (class C1) who underwent sclerotherapy with polidocanol. In the first group, compression for 3 days after each procedure around the clock was prescribed. Patients did not use compression between procedures and after completion of treatment. In the 2nd group, knitwear wearing regimen immediately after procedure was similar. Then, class 2 compression stockings were used for 5 days a week between procedures and after completion of sclerotherapy course. The endpoints were skin hyperpigmentation and telangiectatic matting rates in 4 months after sclerotherapy onset. Severity of hyperpigmentation and comfort of compression stocking wearing were assessed. Results. There were no significant between-group differences in characteristics of patients. In 4 months after onset of treatment, hyperpigmentation rate was 29% and 6% in both groups, respectively (p=0.011). Telangiectatic matting rates were 17.6 and 2.8%, respectively (p=0.052). Severity of hyperpigmentation according to a 4-point scale was 0.53±0.8 and 0.08±0.36, respectively (p=0.041). Patients well tolerated long-term compression. There were no cases interrupted compression. Conclusion. Incidence and severity of hyperpigmentation, as well as telangiectatic matting rate were significantly lower after prolonged compression therapy in patients with reticular varicose veins and telangiectasias.
23 April 2023 in Journal of Venous Disorders
ЦЕЛЬ ИССЛЕДОВАНИЯ определить влияние сулодексида на качество жизни, выраженность симптомов хронического заболевания вен (ХЗВ) и частоту развития нежелательных явлений после проведения радиочастотной облитерации и минифлебэктомии у пациентов с варикозной болезнью классов C2—C4 по классификации CEAP. МАТЕРИАЛ И МЕТОДЫ В исследовании приняли участие 183 пациента. Больные были рандомизированы в две группы: в группу С вошли 93 пациента, которые принимали сулодексид, в группу К (контроль) — 90 пациентов, которым этот препарат не назначали. Фиксировали динамику качества жизни с помощью опросника CIVIQ-20 и тяжесть заболевания по шкале VCSS. Сбор данных осуществляли до операции и через 90 сут. РЕЗУЛЬТАТЫ Выявлено положительное влияние сулодексида на качество жизни (после лечения 58,9±6,9 в группе К и 61,8±8,7 в группе С; p=0,041) и выраженность симптомов ХЗВ (после лечения 4,6±1,38 и 4,23±1,04 соответственно; p=0,039). Не установлено влияния сулодексида на частоту развития нежелательных явлений и осложнений. ЗАКЛЮЧЕНИЕ Для повышения качества жизни и уменьшения выраженности симптомов ХЗВ в раннем послеоперационном периоде оправданно назначение сулодексида.
1 January 2019 in Izvestiya of Saratov University. Physics
SUSaratov State University
+2
23 April 2023 in Journal of Venous Disorders
We analyzed literature data on possible impact of elastic compression on the results of sclerotherapy in patients with reticular varicose veins and telangiectasias. Clinical outcomes and quality of life after sclerotherapy were analyzed depending on postoperative compression. In addition, a special attention was paid to such important complications of sclerotherapy as hyperpigmentation and telangiectatic matting. Literature data confirm heterogeneous results regarding clinical effect of compression after sclerotherapy. There still lack of data to draw any robust conclusions. In most studies, compression is recognized as a method improving cosmetic results and reducing the risk of complications such as hyperpigmentation and telangiectatic matting. However, not all studies confirm such effects. Well-planned studies are necessary to evaluate compression therapy in C1 patients.
6 June 2025 in Journal of Venous Disorders
Hyperpigmentation and telangiectatic matting are frequent adverse events after sclerotherapy in C1 patients. Venous specialists need to identify the risk factors of these adverse events. Objective. To identify the risk factors predisposing to persistent hyperpigmentation and telangiectatic matting after sclerotherapy in C1 patients. Material and methods. A database of 72 C1 patients who undergone sclerotherapy were assessed. The analysis included the following variables: age, body mass index (BMI), duration of the disease, number of sclerotherapy procedures, amount of sclerosing agent used, prolonged compression. Long-term compression implied wearing compression hosiery for 3 days after each procedure, as well as for at least 5 days throughout 4 months after the first procedure. In other cases, patients used compression only for 3 days after each sclerotherapy procedure. Class 2 stockings were used for compression. Results. After 4 months, hyperpigmentation and telangiectatic matting persisted in 12 (16.7%) and 7 (9.7%) patients, respectively. Prolonged post-procedural compression was used by 2 (16.7%) patients with persisted hyperpigmentation and 34 (57.7%) patients without hyperpigmentation (p=0.012). One (14%) patient with persisted telangiectatic matting wore compression stockings for a long time while 35 (58%) patients with this complication used short-term compression (p=0.107). Mean BMI was 25.2±5.4 kg/m2 in patients with hyperpigmentation and 22.2±3.2 kg/m2 in those without hyperpigmentation (p=0.089). In patients with and without persisted telangiectatic matting, BMI was 25.2±4.5 and 22.4±3.6 kg/m2, respectively. The only found risk factor that had an impact on persistence of hyperpigmentation and teleangiectatic matting was prolonged compression therapy in the post–procedural period — 0.09 (95% CI: 0.01—0.63; p=0.015) for hyperpigmentation and 0.09 (95% CI: 0.01—1.0; p=0.05) for telangiectatic matting. Conclusions. The risk of persistent hyperpigmentation and telangiectatic matting after sclerotherapy in C1 patients is significantly reduced by prolonged wearing of compression stockings after treatment.